Modifications of
Frog virus 3 (FV3) is a cytoplasmic deoxyribovirus (for reviews see Granoff, 1969; Kelly & Robertson, 1973) which induces a marked inhibition of host cell RNA synthesis. A number of papers have reported different data concerning the levels of inhibition, ranging from 3o to 8o % early after infection in different cell cultures and with different input multiplicities (Maes & Granoff, I967; Kucera & Granoff, 1968; Costanzo et al. I97O; Guir, Braunwald & Kirn, I97I; Armentrout & McAuslan, 1974) . The inhibition of RNA synthesis is paralleled by a decreased activity of cellular RNA-polymerase II (EC. z. 7.7.6); this impairment could well account for inhibition of RNA synthesis (Costanzo et al. I97O; CampadelliFiume et al. 1971) .
In the experiments reported here we titrated RNA-polymerase II solubilized from FV3-infected and uninfected control cells, at 4 and IZ h after infection, since RNA synthesis continued to decline during this period. The titration was performed by using a labelled derivative of ~-amanitin, a toxic polypeptide from Amanita phalloides, which specifically inhibits mammalian RNA-polymerase II, by binding to the enzyme with a very high affinity (probably in a ratio of I:I; Sperti et al. I973; I974) . The labelled derivative of c~-amanitin was [SH]-O-methyl-demethyl-y-amanitin (o'5 Ci/mol), which was shown to bind to RNA-polymerase II with the same affinity as ~-amanitin (CochetMeilhac & Chambon, 1974) -By means of equilibrium dialysis experiments we calculated the number of [~Hl-amanitin molecules bound to RNA-polymerase II extracted from equal numbers of FV3-infected and uninfected control cells.
All experiments were carried out on BHK cell monolayers infected with FV3 at an input multiplicity of t o to zo p.f.u./cell and incubated at 26 °C, as previously described (CampadelliFiume et al. 1972) ; control cells were mock-infected and thereafter incubated at 26 °C, as the infected cell cultures. RNA-polymerase II was extracted from the nuclei obtained from infected and uninfected cells by homogenization in an isotonic buffer solution (TKMS: o.oI M-tris, pH 7"9, 25 mM-KC1, 5 mM-MgC12, o'25 M-sucrose and fractionation by centrifuging at zooog for 2o rain through a sucrose cushion (TMSD): o.or M-tris, pH 7"9, 5o mMMgCI~, I M-sucrose, I mM-dithiothreitol). Solubilization, partial purification and assay of RNA-polymerase II were performed according to the method of Weaver, Blatti & Rutter 0971). Roeder & Rutter's (1969) fraction V (DEAE-Sephadex eluate) was used throughout, except in amanitin binding site determinations where the non-chromatographed fraction IV was used in order to avoid loss of enzyme. These last experiments were aimed at comparing
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amanitin binding sites present in enzyme preparations obtained from equal numbers of infected and control cells. Amanitin binding sites and dissociation constants of the complexes between amanitin and RNA-polymerase II were determined by equilibrium dialysis experiments, according to the method of Sperti et al. (r973) . They were performed in plexiglass chambers separated by previously stretched cellophane discs (Craig & King, I96Z) , cut from a Visking tube. o'45 ml of the enzyme solutions were placed into one compartment of the dialysis chambers and 0"45 ml of TGMED (0"05 M-tris, pH 7'9, 250/o glycerol, 5 mM-MgCI~, o.I mM-EDTA, o'5 mu-dithiothreitol) containing o.I M-(NH4)2SO4 into the other. Equal amounts of [3H]-amanitin, ranging from I to 5o pmol, were added to both compartments. After continuous shaking for 24 h at 4 °C, two o. I ml samples were withdrawn and counted for radioactivity. Free amanitin concentration (c) was calculated from the radioactivity of the compartment without the enzyme; bound amanitin concentration (b) was calculated from the difference between the radioactivities of the two compartments. The results were plotted according to the equation I/b = I/c+Kd/ac, where a represents the concentration of the amanitin binding sites and Kd the dissociation constant of the complex. The equations for the straight lines were calculated by the least squares method and the significance of the regression lines was estimated by Student's t test of the regression coefficients.
From experiments I and 2 of Table I it appears that the activity of RNA-polymerase II solubilized from equal numbers of control cells varies in the various experiments, as was also observed by other authors (Cochet-Meilhac et al. I974); this variability decreases when RNA-polymerase II is extracted at different times starting from cell cultures which had been seeded at the same time (see experiment 3, Table I ). Therefore, determinations of amanitin binding sites were performed each time on RNA-polymerase II simultaneously extracted from both infected and uninfected cells. The results in Table I show that the number of amanitin binding sites in RNA-polymerase II solubilized from infected cells always decreases, and at 4 and i2 h after infection respectively, becomes one half and about one third of that in RNA-polymerase I[ extracted from an equal number of uninfected cells. It is noteworthy that the decrease of amanitin binding sites parallels the impairment of RNApolymerase II activity.
The dissociation constant (Kd) of the complex between [aH]-amanitin and RNA-poly- merase II extracted from control cells is 3" t × Io -° M, a value which is very close to that found for rat liver RNA-polymerase II by the same technique (Sperti et al. I973) . Surprisingly the Kd of the complex between [3H]-amanitin and RNA-polymerase II extracted from FV3-infected cells at I2 h after infection was found to be higher (7"7 × Io-9 M). These figures represent the means of five determinations; Student's t test for significance of difference between means led to P < o.oI. A minor increase was already observed with RNA-polymerase II extracted from 4 h infected cells (Kd values being 3"9 × 1o-9 M and 6.2 × Io -9 M respectively for the enzymes from uninfected and infected cells). These results indicate that, following FV3 infection, the number of RNA-polymerase II molecules which can bind amanitin decreases, and even those molecules which can bind the toxin exhibit a lower affinity for it. Further experiments were made to measure Michaelis-Menten constants (Kin's) of RNApolymerase II, solubilized from infected and control cells, for ribonucleoside triphosphates (ATP, GTP, CTP, UTP) essentially according to the method of Antony, Wu & Goldthwait (I969).
Km determinations were carried out simultaneously with RNA-polymerase II purified from both infected and uninfected cells. For each nucleotide RNA-polymerase activity was measured in two sets of 7 to Io samples, in which the concentration of the nucleotide under examination varied from o.oI to o'5 mM. The nucleotide being varied was tritium-labelled and its sp. act. was adjusted to o'5 Ci/mol. The concentration of the other three nucleotides was held constant (o-6 mM). Heat denatured calf thymus DNA was used as template; concentration of (NH4)2SO4 was o.I M. The Km values were obtained from double reciprocal plots of the initial velocities of the nucleotide incorporation into RNA versus the nucleotide concentrations; the equations for the straight lines were calculated by the least squares method, the significance of the regression lines being estimated by Student's t test of the regression coefficients.
The apparent Km values show no significant differences between RNA-polymerase II from FV3-infected and uninfected cells (Table a) . This indicates that, in infected cells, the fraction of enzyme molecules which can synthesize RNA exhibits an unchanged affinity for ribonucleotides.
From the present results it seems likely that, in FV3-infected cells, RNA-polymerase II undergoes the following modifications: 0) there is a decrease in the number of molecules able to bind amanitin and to synthesize RNA; (2) the molecules still capable of catalysing RNA synthesis retain a normal affinity for ribonucleotides, although they display a lower affinity for amanitin. 
